CoChat

1163-P: Disparities in Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) Utilization in Pediatric Type 2 Diabetes (T2D)

The DOI matches its Crossref record.

Abstract

Introduction and Objective: Disparities in GLP-1 RA use by race/ethnicity and socioeconomic status are documented in adult T2D. To assess if similar disparities occur in pediatric T2D, the association between GLP-1 RA prescriptions and race/ethnicity amongst Medicaid-insured youths with T2D was examined.

Overview

Integrity signals

Registry

Crossref · 10.2337/db25-1163-p

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 1

Metadata

Authors
CHU, P. Y., KELLY, A., VAJRAVELU, M. E., HENNESSY, S., & AMARAL, S.
Affiliations
Philadelphia, PA, Pittsburgh, PA
Venue
Diabetes
Published
2025-06-20
Volume
74
Issue
Supplement_1
ISSN
0012-1797 (ISSN-L)
OpenAlex
W4411291433
Cited by
1
References
0
Citations by year
2025: 1
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
Diabetes (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
pediatric type 2 diabetes, GLP-1 receptor agonists, racial and ethnic disparities, Latino youth, liraglutide, dulaglutide, exenatide, semaglutide, metformin, insulin, health equity, obesity, socioeconomic status

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 1163-P: Disparities in Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) Utilization in Pediatric Type 2 Diabetes (T2D). https://app.cochat.ai/papers/10.2337/db25-1163-p
The paper
CHU, P. Y., KELLY, A., VAJRAVELU, M. E., HENNESSY, S., & AMARAL, S. (2025). 1163-P: Disparities in Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) Utilization in Pediatric Type 2 Diabetes (T2D). Diabetes. https://doi.org/10.2337/db25-1163-p

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.